These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of celiprolol and other antihypertensive agents on serum lipids and lipoproteins. Hunninghake DB Am Heart J; 1991 Feb; 121(2 Pt 2):696-701. PubMed ID: 1671189 [TBL] [Abstract][Full Text] [Related]
7. Treating hypertension and cardiovascular risk: are there trade-offs? Grimm RH Am Heart J; 1990 Mar; 119(3 Pt 2):729-32; discussion 732. PubMed ID: 1968699 [TBL] [Abstract][Full Text] [Related]
9. Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: lipid alterations and glucose intolerance. Ames RP Am Heart J; 1983 Nov; 106(5 Pt 2):1207-14. PubMed ID: 6637786 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of differential effects of antihypertensive agents on serum lipids. Brook RD Curr Hypertens Rep; 2000 Aug; 2(4):370-7. PubMed ID: 10981172 [TBL] [Abstract][Full Text] [Related]
11. Review: the effects of antihypertensive agents on serum lipids. Madu EC; Reddy RC; Madu AN; Anyaogu C; Harris T; Fraker TD Am J Med Sci; 1996 Aug; 312(2):76-84. PubMed ID: 8701970 [TBL] [Abstract][Full Text] [Related]
12. [Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk]. Samuelsson O; Pennert K; Andersson O; Berglund G; Hedner T; Persson B; Wedel H; Wilhelmsen L Lakartidningen; 1998 Mar; 95(11):1120-3. PubMed ID: 9542820 [TBL] [Abstract][Full Text] [Related]
13. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy. Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435 [TBL] [Abstract][Full Text] [Related]
14. [Effect of various hypotensive drugs on blood lipids in patients with primary arterial hypertension]. Przybył L; Witczak W Pol Tyg Lek; 1985 Apr; 40(17):497-501. PubMed ID: 2861600 [No Abstract] [Full Text] [Related]
15. Lipids and lipoproteins in patients undergoing coronary-artery surgery. Billington T; Janus ED; Sinclair HC Med J Aust; 1989 Mar; 150(6):302-4, 306. PubMed ID: 2566107 [TBL] [Abstract][Full Text] [Related]
16. Risk factors in the management of the unique hypertensive patient. Wright JT J Natl Med Assoc; 1987 Mar; 79 Suppl(Suppl):17-22. PubMed ID: 3586055 [No Abstract] [Full Text] [Related]
18. Effect of antihypertensive agents on lipid metabolism. Cutler R Am J Cardiol; 1983 Feb; 51(4):628-31. PubMed ID: 6131603 [TBL] [Abstract][Full Text] [Related]
19. Effects of prazosin on serum lipids in patients with essential hypertension: a review of the findings presented at the Satellite Symposium on coronary heart disease: hypertension and other risk factors, Milan, 1983. Lowenstein J Am J Cardiol; 1984 Jan; 53(3):21A-23A. PubMed ID: 6141723 [TBL] [Abstract][Full Text] [Related]
20. [Antihypertensive therapy and modification of metabolic risk factors (glucose and lipid metabolism)]. Klein W Z Kardiol; 1992 Jun; 81(6):295-302. PubMed ID: 1353932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]